Transgenic animal models for the functional analysis of vasoactive peptides

被引:2
作者
Bader, M [1 ]
机构
[1] Max Delbruck Ctr Mol Med, D-13122 Berlin, Germany
关键词
renin-angiotensin system; transgenic; animal models; knockout;
D O I
10.1590/S0100-879X1998000900011
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The interplay of vasoactive peptide systems is an essential determinant of blood pressure regulation in mammals. While the endothelin and the renin-angiotensin systems raise blood pressure by inducing vasoconstriction and sodium retention, the kallikrein-kinin and the natriuretic-peptide systems reduce arterial pressure by eliciting vasodilatation and natriuresis. Transgenic technology has proven to be very useful for the functional analysis of vasoactive peptide systems. As an outstanding example, transgenic rats overexpressing the mouse Ren-2 renin gene in several tissues become extremely hypertensive. Several other transgenic rat and mouse strains with genetic modifications of components of the renin-angiotensin system have been developed in the past decade. Moreover, in recent years gene-targeting technology was employed to produce mouse strains lacking these proteins. The established animal models as well as the main insights gained by their analysis are summarized in this review.
引用
收藏
页码:1171 / 1183
页数:13
相关论文
共 128 条
[61]   MALE-FEMALE DIFFERENCES IN FERTILITY AND BLOOD-PRESSURE IN ACE-DEFICIENT MICE [J].
KREGE, JH ;
JOHN, SWM ;
LANGENBACH, LL ;
HODGIN, JB ;
HAGAMAN, JR ;
BACHMAN, ES ;
JENNETTE, JC ;
OBRIEN, DA ;
SMITHIES, O .
NATURE, 1995, 375 (6527) :146-148
[62]  
KRIMPENFORT P, 1991, BIO-TECHNOL, V9, P844, DOI 10.1038/nbt0991-844
[63]   Transcriptional and posttranscriptional mechanisms regulate human renin gene expression in Calu-6 cells [J].
Lang, JA ;
Ying, LH ;
Morris, BJ ;
Sigmund, CD .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1996, 271 (01) :F94-F100
[64]  
LANGFORD KG, 1991, J BIOL CHEM, V266, P15559
[65]  
LEE KJ, 1992, J BIOL CHEM, V267, P15875
[66]   DIFFERENTIAL GENE-EXPRESSION OF RENIN AND ANGIOTENSINOGEN IN THE TGR(MREN-2)27 TRANSGENIC RAT [J].
LEE, MA ;
BOHM, M ;
KIM, S ;
BACHMANN, S ;
BACHMANN, J ;
BADER, M ;
GANTEN, D .
HYPERTENSION, 1995, 25 (04) :570-580
[67]   Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27 [J].
Lee, MA ;
Bohm, M ;
Paul, M ;
Bader, M ;
Ganten, U ;
Ganten, D .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 270 (06) :E919-E929
[68]   CIRCADIAN BLOOD-PRESSURE VARIATION IN TRANSGENIC HYPERTENSIVE RATS [J].
LEMMER, B ;
MATTES, A ;
BOHM, M ;
GANTEN, D .
HYPERTENSION, 1993, 22 (01) :97-101
[69]   Expression of the SM22 alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells [J].
Li, L ;
Miano, JM ;
Mercer, B ;
Olson, EN .
JOURNAL OF CELL BIOLOGY, 1996, 132 (05) :849-859
[70]   Role of paraventricular angiotensin AT(1) receptors in salt-sensitive hypertension in mRen-2 transgenic rats [J].
Li, P ;
Morris, M ;
Diz, DI ;
Ferrario, CM ;
Ganten, D ;
Callahan, MF .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1996, 270 (05) :R1178-R1181